SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-003464
Filing Date
2020-10-16
Accepted
2020-10-16 08:00:25
Documents
72
Period of Report
2019-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q organicell_10q-073119.htm 10-Q 616446
2 CERTIFICATION organicell_ex3101.htm EX-31.1 9796
3 CERTIFICATION organicell_ex3102.htm EX-31.2 8754
4 CERTIFICATION organicell_ex3201.htm EX-32.1 3576
5 CERTIFICATION organicell_ex3202.htm EX-32.2 3665
  Complete submission text file 0001683168-20-003464.txt   5134719

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bpsr-20190731.xml EX-101.INS 835186
7 XBRL SCHEMA FILE bpsr-20190731.xsd EX-101.SCH 62717
8 XBRL CALCULATION FILE bpsr-20190731_cal.xml EX-101.CAL 49139
9 XBRL DEFINITION FILE bpsr-20190731_def.xml EX-101.DEF 274233
10 XBRL LABEL FILE bpsr-20190731_lab.xml EX-101.LAB 370121
11 XBRL PRESENTATION FILE bpsr-20190731_pre.xml EX-101.PRE 342168
Mailing Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140
Business Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-55008 | Film No.: 201242801
SIC: 3790 Miscellaneous Transportation Equipment
Office of Manufacturing